Item 7.01 Regulation FD Disclosure.
On November 18, 2022, Microbot Medical Inc. (the “Company”) issued a press
release announcing that in a continuation of its efforts to create barriers and
expand its global intellectual property portfolio for the LIBERTY® Robotic
System, the Company was issued a design patent allowance by the US Patent &
Trademark Office (USPTO), covering the LIBERTY Robotic System’s remote
controller unique interface design.
The press release, which is furnished as Exhibit 99.1 to this Current Report on
Form 8-K, is incorporated herein by reference. The information in this report
(including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not
be deemed to be “filed” for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that section. This report will not be deemed an admission as to the materiality
of any information herein (including Exhibit 99.1).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit Number Description 99.1 Press Release dated November 18, 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses